Trials / Completed
CompletedNCT02674048
Metvix Daylight PDT in Actinic Keratosis
Observational Study to Evaluate Clinical Practice and Satisfaction With Metvix® Daylight Photodynamic Therapy (PDT) in the Treatment of Mild and/or Moderate Actinic Keratosis of the Face and/or the Scalp
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 406 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective non-interventional study conducted in Australia, Brazil, Mexico and Europe to evaluate clinical practice with Metvix Daylight PDT in the treatment of mild to moderate actinic keratosis of the face/scalp and to assess physician and patient satisfaction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Metvix |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2016-10-01
- Completion
- 2016-11-01
- First posted
- 2016-02-04
- Last updated
- 2021-02-17
Locations
7 sites across 7 countries: Australia, France, Italy, Netherlands, Spain, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT02674048. Inclusion in this directory is not an endorsement.